Literature DB >> 2761367

Medical students' and residents' estimates of cardiac risk.

T G Tape1, R S Wigton.   

Abstract

Resident physicians' and medical students' perceptions of atherosclerotic heart disease (ASHD) risks and their understanding of risk appraisal concepts were studied. Subjects estimated the average risks of death from ASHD, from motor vehicle accidents, and from all causes for men in three age groups. Given a patient with severe hypertension, they then estimated relative risk and used their estimates to calculate individual patient risks. Risk estimates varied widely. Only 36% of the subjects were consistently accurate estimators of ASHD and all-causes risks. Subjects who had family histories of heart disease performed significantly better than others. Only about half the subjects were able to compute the hypertensive patient's risk correctly. Thus, residents and students were not adept at estimating the average risks of death from various causes or using the estimates to assess a patient's risk. Better physician understanding of these concepts might lead to improved patient counseling in risk factor reduction.

Entities:  

Mesh:

Year:  1989        PMID: 2761367     DOI: 10.1177/0272989X8900900304

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  3 in total

1.  How do physicians talk with their patients about risks?

Authors:  A Kalet; J C Roberts; R Fletcher
Journal:  J Gen Intern Med       Date:  1994-07       Impact factor: 5.128

2.  General practitioners' tacit and stated policies in the prescription of lipid lowering agents.

Authors:  J S Evans; C Harries; I Dennis; J Dean
Journal:  Br J Gen Pract       Date:  1995-01       Impact factor: 5.386

3.  Physicians' tacit and stated policies for determining patient benefit and referral to cardiac rehabilitation.

Authors:  Jason W Beckstead; Mark V Pezzo; Theresa M Beckie; Farnaz Shahraki; Amanda C Kentner; Sherry L Grace
Journal:  Med Decis Making       Date:  2013-06-19       Impact factor: 2.583

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.